Who should not use Mounjaro? A guide to contraindications
•
3 min read
The FDA has issued a boxed warning for Mounjaro (tirzepatide) concerning the risk of thyroid C-cell tumors based on animal studies. This critical safety information helps determine **who should not use Mounjaro**, highlighting contraindications and significant risks associated with the medication.